Therapeutic Uses
Anti-Cancer / Oncology
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
N-(3-Ethynylphenyl-1,2,3,4,5,6-13C6)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride
Application Notes
Useful research chemical for a range of applications
Purity by HPLC
Not less than 90%
Hazard Compound
No -Refer MSDS for accurate information
Erlotinib-13C6 Hydrochloride is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Erlotinib-13C6 Hydrochloride usage and description
Erlotinib 13C6 hydrochloride is a chemotherapeutic drug that is used in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. It works by inhibiting the activity of the epidermal growth factor receptor (EGFR), which is a protein that is overexpressed in some cancer cells and promotes their growth and survival. By blocking the activity of EGFR, erlotinib 13C6 hydrochloride can slow down or stop the growth of cancer cells, which can help to shrink tumors and improve the patient’s condition.
Erlotinib 13C6 hydrochloride is an isotopically labeled version of erlotinib hydrochloride, which means that it contains six carbon atoms that have been replaced with the stable isotope carbon-13. This labeling is useful for researchers who want to study the metabolism and pharmacokinetics of erlotinib in the body, because it allows them to track the drug using mass spectrometry and other analytical techniques.
The chemical formula of erlotinib 13C6 hydrochloride is C22H16ClN3O4. It is a white to pale yellow crystalline powder that is soluble in water, methanol, and ethanol. The drug is typically administered orally in tablet form, and the recommended dosage varies depending on the patient’s condition and other factors.
Overall, erlotinib 13C6 hydrochloride is a valuable tool for cancer researchers and clinicians who are working to develop better treatments for lung and pancreatic cancer. By inhibiting EGFR activity, this drug has the potential to improve patient outcomes and extend survival in these difficult-to-treat cancers.
